In normal cells, CDK4/6 is rigorously regulated by members of the INK4 CDK inhibitor family; however, genetic changes or overexpression of cyclin D1-3, CDK4/6, and INK4 family members cause the cell cycle to become dysregulated, resulting in tumor formation. This evidence concerns the gene CCND1 and neoplasm.